Clinical Liver Disease
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 111:15:50
- More information
Informações:
Synopsis
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episodes
-
![16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection]()
16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection
25/10/2020 Duration: 09minAudible Article by Camilla S. Graham
-
![16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics]()
16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics
25/10/2020 Duration: 09minAudible Article by Lynn E. Taylor
-
![16-1: State of the Hepatitis C Virus Care Cascade]()
16-1: State of the Hepatitis C Virus Care Cascade
25/10/2020 Duration: 09minAudible Article by David L. Thomas
-
![16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response]()
16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response
25/10/2020 Duration: 09minAudible Article by Brian Pearlman
-
![16-1: Management of Direct-Acting Antiviral Failures]()
16-1: Management of Direct-Acting Antiviral Failures
25/10/2020 Duration: 09minAudible Article by Maryam Alimirah, Omar Sadiq, and Stuart C. Gordon
-
![16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response]()
16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response
25/10/2020 Duration: 09minAudible Article by Brian Pearlman
-
![16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection]()
16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection
25/10/2020 Duration: 09minAAudible Article by Camilla S. Graham
-
![16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics]()
16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics
25/10/2020 Duration: 09minAudible Article by Lynn E. Taylor
-
![16-1: State of the Hepatitis C Virus Care Cascade]()
16-1: State of the Hepatitis C Virus Care Cascade
25/10/2020 Duration: 09minAudible Article by David L. Thomas
-
![16-1: Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care]()
16-1: Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care
25/10/2020 Duration: 09minAudible Article by Sanjeev Arora and Karla Thornton
-
![16-1: HCV Elimination in a Health Network Serving Indigenous Communities in Northern California]()
16-1: HCV Elimination in a Health Network Serving Indigenous Communities in Northern California
25/10/2020 Duration: 09minAudible Article by Kathleen Cassel and Gregory Carlson
-
![16-1: Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis]()
16-1: Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis
25/10/2020 Duration: 09minAudible Article by Laila Fozouni and Jennifer C. Lai
-
![16-S1: Hemochromatosis: Ancient to the Future]()
16-S1: Hemochromatosis: Ancient to the Future
25/10/2020 Duration: 09minInterview with Paul C. Adams
-
![16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?]()
16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?
25/10/2020 Duration: 09minInterview with Mina Niazi
-
![16-S1: A History of Coagulopathy in Liver Disease: Legends and Myths]()
16-S1: A History of Coagulopathy in Liver Disease: Legends and Myths
25/10/2020 Duration: 09minInterview with Patrick Northup
-
![16-S1: Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences]()
16-S1: Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences
25/10/2020 Duration: 09minInterview with Wiliam M. Lee
-
![16-S1: We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B]()
16-S1: We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B
25/10/2020 Duration: 09minInterview with Robert G. Gish
-
![16-S1: The History of Hepatitis A]()
-
![16-S1: Hemochromatosis: Ancient to the Future]()
16-S1: Hemochromatosis: Ancient to the Future
25/10/2020 Duration: 09minAudible Article by Paul C. Adams
-
![16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?]()
16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?
25/10/2020 Duration: 09minAudible Article by Mina Niazi and Juan G. Abraldes
